Molecular Epidemiology of SARS-CoV-2 within Accra Metropolis Postlockdown

Table 4

Risk factors and predictors associated with SARS-CoV-2 infection.

Categories	Odds ratio
	Crude (CI95)	P value	Adjusted (CI95)	P value
Gender; (ref: female)	1		1
Male	0.62 (0.37–1.06)	0.074	0.5 (0.37–1.51)	0.421
Age group; (ref: ≥71 years)	1		1
≤10 years	0.66 (0.26–1.84)	0.424	0.50 (0.07–3.54)	0.490
11–20 years	0.46 (0.17–1.38)	0.161	0.59 (0.10–3.60)	0.565
21–30 years	0.33 (0.17–0.65)	0.001	0.51 (0.10–2.74)	0.432
31–40 years	1.65 (0.90–3.05)	0.120	2.05 (0.46–9.14)	0.346
41–50 years	1.80 (0.92–3.49)	0.089	2.56 (0.56–11.61)	0.225
51–60 years	0.79 (0.37–1.61)	0.536	0.79 (0.16–3.93)	0.776
61–70 years	0.46 (0.17–1.38)	0.161	0.80 (0.13–4.86)	0.809
Nationality; (ref: non-Ghanaian)
Ghanaian	0.78 (0.41–1.43)	0.434	0.82 (0.36–1.88)	0.641
Symptoms status; (ref: asymptomatic)	1		1
Symptomatic			35.04 (3.00–108.72)
Clinical symptoms (ref: no)	1		1
Symptomatic	16.50 (7.85–33.70)	<0.001	35.04 (3.00–108.72)	0.005
Chills (yes)	45.79 (7.49–98.65)	<0.001	62.99 (0.96–124.59)	0.052
Cough (yes)	6.03 (1.66–21.89)	0.006	18.11 (8.37–39.53)	<0.001
Diarrhoea (yes)	0.14 (0.01–0.96)	0.049	0.09 (0.001–6.48)	0.271
Fever >38°C (yes)	0.11 (0.02–0.53)	0.002	0.90 (0.11–7.36)	0.925
Nausea (yes)	0.21 (0.02–1.86)	0.167	0.74 (0.02–25.42)	0.866
Dyspnoea (yes)	4.71 (0.54–68.54)	0.167	1.05 (0.03–33.92)	0.980
Sore throat (yes)	11.25 (4.61–27.76)	<0.001	1.50 (0.28–8.12)	0.636
Headache (yes)	16.01 (5.38–44.12)	<0.001	3.32 (0.51–21.51)	0.208
Joint pain (yes)	4.71 (0.54–68.54)	<0.001	0.09 (0.001–5.29)	0.244
Muscle ache (yes)	8.75 (1.87–42.10)	0.002	0.74 (0.03–20.36)	0.859
Runny nose (yes)	7.18 (2.43–20.97)	<0.001	0.37 (0.05–3.06)	0.357
Body weakness (yes)	9.66 (1.55–18.74)	0.014	2.73 (0.03–33.77)	0.659